Rare diseases
Investigational molecules
Locations
2 Bloor Street West Floor 7, M4W 3E2
Medicenna Therapeutics Inc. is focused on clinical research in advanced solid tumors, with attention to cancers that remain difficult to treat across multiple organ sites.
The sponsor’s current research activity centers on treatment approaches for patients with selected advanced malignancies, reflecting interest in broad oncology applications rather than a single tumor type.
Medicenna Therapeutics Inc. runs clinical trials in conditions such as Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
IrelandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
